Subchronic effects of perfluorooctanesulfonate exposure on inflammation in adult male C57BL/6 mice

Environmental Toxicology

Volumn 27, Issue 5, 2012, Pages 285-296

  Dong, Guang Hui ^a   Zhang, Ying Hua ^a   Zheng, Li ^a   Liang, Zai Fu ^a   Jin, Yi He ^a,b   He, Qin Cheng ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b DALIAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Interleukin 1 ; Interleukin 6; Lipopolysaccharide; Perfluorooctanesulfonate; Tumor necrosis factor

Indexed keywords

INTERLEUKIN-1; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; PERFLUOROOCTANE SULFONATES; TUMOR NECROSIS FACTORS;

GLYCOPROTEINS; MAMMALS; PATHOLOGY;

MACROPHAGES;

CD11B ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PERFLUOROOCTANESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; CHEMICAL POLLUTANT; DOSE-RESPONSE RELATIONSHIP; MALE BEHAVIOR; POLLUTION EXPOSURE; POLYSACCHARIDE; RODENT; SERUM; TOXICITY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHRONIC TOXICITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RESPONSE; ENVIRONMENTAL EXPOSURE; FLOW CYTOMETRY; FOOD INTAKE; GENE EXPRESSION; INFLAMMATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; ONCOGENE C MYC; PERITONEUM LAVAGE; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SPLEEN; SPLEEN CELL; SPLENIC MACROPHAGE; TOXICITY TESTING;

ALKANESULFONIC ACIDS; ANIMALS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROCARBONS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 84859769112     PISSN: 15204081     EISSN: 15227278     Source Type: Journal    
DOI: 10.1002/tox.20642     Document Type: Article

References (53)

1. 3M Company. 2002. 104-week dietary chronic toxicity and carcinogenicity study with perfluorooctane sulfonic acid potassium salt (PFOS; T-6295) in rats. Final Report, 3M T-6295 (Covance study no.:6329-183), Volumes I-IX, 4068 pages, January 2, 2002. 3M, St. Paul, Minnesota.
2. Abbott BD. 2009. Review of the expression of peroxisome proliferators activated receptors alpha (PPAR-alpha), beta (PPAR-beta), and gamma (PPAR-gamma) in rodent and human development. Reprod Toxicol 27: 246-257.
3. Alexander BH, Olsen GW, Burris JM, Mandel JH, Mandel JS. 2003. Mortality of employees of a perfluorooctanesulphonyl fluoride manufacturing facility. Occup Environ Med 60: 722-729.
4. Ankley GT, Kuehl DW, Kahl MD, Jensen KM, Linnum A, Leino RL, Villeneuvet DA. 2005. Reproductive and developmental toxicity and bioconcentration of perfluorooctanesulfonate in a partial life-cycle test with the fathead minnow (Pimephales promelas). Environ Toxicol Chem 24: 2316-2324.
5. Asakawa A, Toyoshima M, Harada KH, Fujimiya M, Inoue K, Koizumi A. 2008. The ubiquitous environmental pollutant perfluorooctanoicacid inhibits feeding behavior via peroxisome proliferator-activated receptor-alpha. Int J Mol Med 21: 439-445.
6. Balkwill F. 2006. TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev 25: 409-416.
7. Berger J, Machackova M, Berger Z. 2005. Effects of feed restriction on the nucleolar structure and function in lymphocytes. Basic Clin Pharmacol Toxicol 97: 236-237.
8. Burris JM, Lundberg JK, Olsen GW, Simpson C, Mandel JH. 2002. Determination of serum half-lives of several fluorochemicals. Interim Report No. 2. St. Paul, MN:3M Company. U.S. EPA docket AR-226-1086. Washington, DC:U.S. Environmental Protection Agency.
9. Calafat AM, Kuklenyik Z, Reidy JA.Caudill SP, Tully JS, Needham LL. 2007. Serum concentrations of 11 polyfluoroalkyl compounds in the U.S. population: Data from the national health and nutrition examination survey (NHANES). Environ Sci Technol 41: 2237-2242.
10. Chinetti G, Fruchart JC, Staels B. 2000. Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res 49: 497-505.
11. Clarke DB, Bailey VA, Routledge A, Lloyd AS, Hird S, Mortimer DN, Gem M. 2010. Dietary intake estimate for perfluorooctanesulphonic acid (PFOS) and other perfluorocompounds (PFCs) in UK retail foods following determination using standard addition LC-MS/MS. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 27: 530-545.
12. Curran I, Hierlihy SL, Liston V, Pantazopoulos P, Nunnikhoven A, Tittlemier S, Barker M, Trick K, Bondy G. 2008. Altered fatty acid homeostasis and related toxicologic sequelae in rats exposed to dietary potassium perfluorooctanesulfonate (PFOS). J Toxicol Environ Health A 71: 1526-1541.
13. Daynes RA, Jones DC. 2002. Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol 2: 748-759.
14. Devchand PR, Keller H, Peters JM, Vazquez M, Gonzalez FJ, Wahli W. 1996. The PPARalpha-leukotriene B4 pathway to inflammation control. Nature 384: 39-43.
15. de Vos MG, Huijbregts MA, van den Heuvel-Greve MJ, Vethaak AD, Van de Vijver KI, Leonards PE, van Leeuwen SP, de Vooqt P, Hendriks AJ. 2008. Accumulation of perfluorooctane sulfonate (PFOS) in the food chain of the Western Scheldt estuary: Comparing field measurements with kinetic modeling. Chemosphere 70: 1766-1773.
16. DeWitt JC, Copeland CB, Strynar MJ, Luebke RW. 2008. Perfluorooctanoic acid-induced immunomodulation in adult C57BL/6J or C57BL/6N female mice. Environ Health Perspect 116: 644-650.
17. Dong GH, Zhang YH, Zheng L, Liu W, Jin YH, He QC. 2009. Chronic effects of perfluorooctanesulfonate exposure on immunotoxicity in adult male C57BL/6 mice. Arch Toxicol 83: 805-815.
18. Egeghy PP, Lorber M. 2010. An assessment of the exposure of Americans to perfluorooctane sulfonate: A comparison of estimated intake with values inferred from NHANES data. J Expo Sci Environ Epidemiol doi:10.1038/jes.2009.73.
19. Giesy JP, Kannan K. 2001. Global distribution of perfluorooctane sulfonate in wildlife. Environ Sci Technol 35: 1339-1342.
20. Hansen KJ, Clemen LA, Ellefson ME, Johnson HO. 2001. Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices. Environ Sci Technol 35: 766-770.
21. Hebert CD, Yuan J, Dieter MP. 1994. Comparison of the toxicity of cinnamaldehyde when administered by microencapsulation in feed or by corn oil gavage. Food Chem Toxicol 32: 1107-1115.
22. Hosea HJ, Rector ES, Taylor CG. 2004. Dietary repletion can replenish reduced T cell subset numbers and lymphoid organ weight in zinc-deficient and energy-restricted rats. Br J Nutr 91: 741-747.
23. Houde M, Bujas TA, Small J, Wells RS, Fair PA, Bossart GD, Solomon KR, Muir DC. 2006. Biomagnification of perfluoroalkyl compounds in the bottlenose dolphin (Tursiops truncatus) food web. Environ Sci Technol 40: 4138-4144.
24. Hu W, Jones PD, DeCoen W, King L, Fraker P, Newsted J, Giesy JP. 2003. Alterations in cell membrane properties caused by perfluorinated compounds. Comp Biochem Physiol C Toxicol Pharmacol 135: 77-88.
25. Jin Y, Saito N, Harada KH, Inoue K, Koizumi A. 2007. Historical trends in human serum levels of perfluorooctanoate and perfluorooctane sulfonate in Shenyang, China. Tohoku J Exp Med 212: 63-70.
26. Joensen UN, Bossi R, Leffers H, Jensen AA, Skakkebaek NE, Jørgensen N. 2009. Do perfluoroalkyl compounds impair human semen quality? Environ Health Perspect 117: 923-927.
27. Kapetanovic IM, Krishnaraj R, Martin-Jimenez T, Yuan L, van Breemen RB, Lyubimov A. 2006. Effects of oral dosing paradigms (gavage versus diet) on pharmacokinetics and pharmacodynamics. Chem Biol Interact 164: 68-75.
28. Keil DE, Mehlmann T, Butterworth L, Peden-Adams MM. 2008. Gestational exposure to perfluorooctane sulfonate suppresses immune function in B6C3F1 Mice. Toxicol Sci 103: 77-85.
29. Kim SH, Sharma RP. 2004. Mercury-induced apoptosis and necrosis in murine macrophages: Role of calcium-induced reactive oxygen species and p38 mitogen-activated protein kinase signaling. Toxicol Appl Pharmacol 196: 47-57.
30. Kim SH, Lee S, Suk K, Bark H, Jun CD, Kim DK, Choi CH, Yoshimura T. 2007. Discoidin domain receptor 1 mediates collagen-induced nitric oxide production in J774A. 1 murine macrophages. Free Radic Biol Med 42: 343-352.
31. Lefebvre DE, Curran I, Armstrong C, Coady L, Parenteau M, Liston V, Barker M, Aziz S, Rutherford K, Bellon-Gagnon P, Shenton J, Mehta R, Bondy G. 2008. Immunomodulatory effects of dietary potassium perfluorooctane sulfonate (PFOS) exposure in adult sprague-dawley rats. J Toxicol Environ Health A 71: 1516-1525.
32. Maes M. 2008. The cytokine hypothesis of depression: inflammation, oxidative and nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Neuro Endocrinol Lett 29: 287-291.
33. Melzer D, Rice N, Depledge MH, Henley WE, Galloway TS. 2010. Association between serum perfluoroctanoic acid (PFOA) and thyroid disease in the NHANES study. Environ Health Perspect doi:10.1289/ehp.0901584.
34. Naile JE, Khim JS, Wang T, Chen C, Luo W, Kwon BO, Park J, Koh CH, Jones PD, Lu Y, Giesy JP. 2010. Perfluorinated compounds in water, sediment, soil and biota from estuarine and coastal areas of Korea. Environ Pollut 158: 1237-1244.
35. Organization for Economic Co-operation and Development. 2002. Hanzard assessment of perfluorooctane sulfonate (PFOS) and its salts. Available at:
36. Qazi MR, Bogdanska J, Butenhoff JL, Nelson BD, DePierre JW, Abedi-Valugerdi M. 2009a. High-dose, short-term exposure of mice to perfluorooctanesulfonate (PFOS) or perfluorooctanoate (PFOA) affects the number of circulating neutrophils differently, but enhances the inflammatory responses of macrophages to lipopolysaccharide (LPS) in a similar fashion. Toxicology 262: 207-214.
37. Qazi MR, Xia Z, Bogdanska J, Chang SC, Ehresman DJ, Butenhoff JL, Nelson BD, DePierre JW, Abedi-Valugerdi M. 2009b. The atrophy and changes in the cellular compositions of the thymus and spleen observed in mice subjected to short-term exposure to perfluorooctanesulfonate are high-dose phenomena mediated in part by peroxisome proliferator-activated receptor-alpha (PPAR-alpha). Toxicology 260: 68-76.
38. Qazi MR, Nelson BD, Depierre JW, Abedi-Valugerdi M. 2010. 28-Day dietary exposure of mice to a low total dose (7 mg/kg) of perfluorooctanesulfonate (PFOS) alters neither the cellular compositions of the thymus and spleen nor humoral immune responses: Does the route of administration play a pivotal role in PFOS-induced immunotoxicity? Toxicology 267: 132-139.
39. Peden-Adams MM, Keller JM, EuDaly JG, Berger J, Gilkeson GS, Keil DE. 2008. Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate. Toxicol Sci 104: 144-154.
40. Roberts RA. 1999. Peroxisome proliferators: Mechanisms of adverse effects in rodents and molecular basis for species differences. Arch Toxicol 73(8/9): 413-418.
41. Redl H, Bahrami S, Schlag G, Traber DL. 1993. Clinical detection of LPS and animal models of endotoxemia. Immunobiology 187: 330-345.
42. Salkowski CA, Neta R, Wynn TA, Strassmann G, van Rooijen N, Vogel SN. 1995. Effect of liposome-mediated macrophage depletion on LPS-induced cytokine gene expression and radioprotection. J Immunol 155: 3168-3179.
43. Shacter E, Weitzman SA. 2002. Chronic inflammation and cancer. Oncology (Williston Park) 16: 217-226.
44. Son HY, Lee S, Tak EN, Cho HS, Shin HI, Kim SH, Yang JH. 2009. Perfluorooctanoic acid alters T lymphocyte phenotypes and cytokine expression in mice. Environ Toxicol 24: 580-588.
45. Steenland K, Tinker S, Shankar A, Ducatman A. 2010. Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA. Environ Health Perspect 118: 229-233.
46. Stein CR, Savitz DA, Dougan M. 2009. Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome. Am J Epidemiol 170: 837-846.
47. Toms LM, Calafat AM, Kato K, Thompson J, Harden F, Hobson P, Sjödin A, Mueller JF. 2009. Polyfluoroalkyl chemicals in pooled blood serum from infants, children, and adults in Australia. Environ Sci Technol 43: 4194-4199.
48. Weller I. 2001. Secondary immunodeficiency. In: Roitt I, Brostoff J, Male DK, editors. Immunology, 6th ed. Edinburgh, Scotland: Mosby. pp 315-317.
49. Yang Q, Xie Y, Eriksson AM, Nelson BD, DePierre JW. 2001. Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluorooctanoic acid in mice. Biochem Pharmacol 62: 1133-1140.
50. Yang Q, Abedi-Valugerdi M, Xie Y, Zhao XY, Moller G, Nelson BD, DePierre JW. 2002. Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid. Int Immunopharmacol 2(2/3): 389-397.
51. Yu WG, Liu W, Jin YH. 2009. Effects of perfluorooctane sulfonate on rat thyroid hormone biosynthesis and metabolism. Environ Toxicol Chem 28: 990-996.
52. Yuan JH, Goehl TJ, Murrill E, Moore R, Clark J, Hong HL, Irwin RD. 1994. Toxicokinetics of pentachlorophenol in the F344 rat. Gavage and dosed feed studies. Xenobiotica 24: 553-560.
53. Zheng L, Dong GH, Jin YH, He QC. 2009. Immunotoxic changes associated with a 7-day oral exposure to perfluorooctanesulfonate (PFOS) in adult male C57BL/6 mice. Arch Toxicol 83: 679-689.